UniProt ID | ETAA1_HUMAN | |
---|---|---|
UniProt AC | Q9NY74 | |
Protein Name | Ewing's tumor-associated antigen 1 {ECO:0000312|HGNC:HGNC:24648} | |
Gene Name | ETAA1 {ECO:0000312|HGNC:HGNC:24648} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 926 | |
Subcellular Localization | Nucleus . Localizes at sites of DNA damage following replication stress (PubMed:27601467, PubMed:27723720, PubMed:27723717). Recruited to stalled replication forks via interaction with RPA1 and RPA2 subunits of the RPA complex (PubMed:27601467, PubMe | |
Protein Description | Replication stress response protein that accumulates at DNA damage sites and promotes replication fork progression and integrity. [PubMed: 27601467] | |
Protein Sequence | MSRRRKHDDSPSPKKTPHKTVAAEECGSVVEPGRRRLRSARGSWPCGAREGPPGPVRQREQPPTAALCSKSNPEERYETPKRALKMDSLSSSFSSPNDPDGQNDIFWDQNSPLTKQLGKGRKKQIYTTDSDEISHIVNRIAPQDEKPTTNSMLDMWIGETAIPCTPSVAKGKSRAKISCTKLKTQSQEEELMKLAKQFDKNMEELDVIQEQNKRNYDFTQMISETEILSNYKDNIQMWSLHNIVPEIDNATKKPIKGNTKISVANNQNSSQKPFDQIAEAAFNAIFDGSTQKCSGQLSQELPEAFWSTSNTTFVKTNALKEEKIITNETLVIEKLSNKTPRSLSSQVDTPIMTKSCVTSCTKEPETSNKYIDAFTTSDFEDDWENLLGSEPFAMQNIDMPELFPSKTAHVTDQKEICTFNSKTVKNTSRANTSPDARLGDSKVLQDLSSKTYDRELIDAEYRFSPNSNKSNKLSTGNKMKFENSSNKIVIQDEIQNCIVTSNLTKIKEDILTNSTEASERKSALNTRYSNEQKNKCILNQSIKAPVNTDLFGSANLGSKTSVSNPNQTSASKVGSFFDDWNDPSFANEIIKACHQLDNTWEADDVDDDLLYQACDDIERLTQQQDIRKDSKTSESICEINNNSEHGAKLTQQQDIRKDSKTSESICEINNNSEHGAKNMFAISKQGSNLVQSKHLNPGSISVQTSLTNSSQIDKPMKMEKGEMYGNSPRFLGATNLTMYSKISNCQINNLHVSYTNTDVPIQVNSSKLVLPGSSSLNVTSDHMNTEITTYKKKLSTNQPCHKTVTDEAQSNLNTTVGFSKFTFTRMKNSQILSQFNQNCITGSMSDTKITQGVEKKKGVNPLLEEAVGQQSLVKLSESLKQSSKEEEEKNRKCSPEEIQRKRQEALVRRMAKARASSVNAAPTSFL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | RRRKHDDSPSPKKTP CCCCCCCCCCCCCCC | 33.08 | 28985074 | |
12 | Phosphorylation | RKHDDSPSPKKTPHK CCCCCCCCCCCCCCC | 53.99 | 28985074 | |
39 | Phosphorylation | PGRRRLRSARGSWPC CCCHHHHHCCCCCCC | 27.23 | 28555341 | |
43 | Phosphorylation | RLRSARGSWPCGARE HHHHCCCCCCCCCCC | 23.45 | 27251275 | |
85 | Sumoylation | ETPKRALKMDSLSSS CCHHHHHHHHHHCCC | 39.41 | 28112733 | |
95 | Phosphorylation | SLSSSFSSPNDPDGQ HHCCCCCCCCCCCCC | 26.22 | - | |
119 | Methylation | PLTKQLGKGRKKQIY HHHHHCCCCCCCEEE | 65.22 | - | |
122 | Ubiquitination | KQLGKGRKKQIYTTD HHCCCCCCCEEEECC | 58.67 | - | |
123 | Ubiquitination | QLGKGRKKQIYTTDS HCCCCCCCEEEECCH | 40.33 | 29967540 | |
130 | Phosphorylation | KQIYTTDSDEISHIV CEEEECCHHHHHHHH | 34.74 | 25159151 | |
146 | Acetylation | RIAPQDEKPTTNSML HHCCCCCCCCCCCHH | 56.82 | 19818169 | |
165 | Phosphorylation | GETAIPCTPSVAKGK CCCCCCCCHHHHCCC | 17.16 | 24719451 | |
167 | Phosphorylation | TAIPCTPSVAKGKSR CCCCCCHHHHCCCCC | 19.29 | 28060719 | |
178 | Phosphorylation | GKSRAKISCTKLKTQ CCCCCEEEECCCCCC | 18.28 | - | |
183 | Sumoylation | KISCTKLKTQSQEEE EEEECCCCCCCHHHH | 46.18 | - | |
183 | Sumoylation | KISCTKLKTQSQEEE EEEECCCCCCCHHHH | 46.18 | - | |
183 | Ubiquitination | KISCTKLKTQSQEEE EEEECCCCCCCHHHH | 46.18 | - | |
184 | Phosphorylation | ISCTKLKTQSQEEEL EEECCCCCCCHHHHH | 43.84 | 20363803 | |
186 | Phosphorylation | CTKLKTQSQEEELMK ECCCCCCCHHHHHHH | 44.80 | 25159151 | |
193 | Ubiquitination | SQEEELMKLAKQFDK CHHHHHHHHHHHHHH | 58.90 | 29967540 | |
196 | Sumoylation | EELMKLAKQFDKNME HHHHHHHHHHHHCHH | 63.03 | - | |
196 | Sumoylation | EELMKLAKQFDKNME HHHHHHHHHHHHCHH | 63.03 | - | |
200 | Ubiquitination | KLAKQFDKNMEELDV HHHHHHHHCHHHHHH | 60.53 | 29967540 | |
213 | Ubiquitination | DVIQEQNKRNYDFTQ HHHHHHHHCCCCHHH | 41.54 | 29967540 | |
256 | Acetylation | NATKKPIKGNTKISV CCCCCCCCCCCEEEE | 55.42 | 91065 | |
260 | Sumoylation | KPIKGNTKISVANNQ CCCCCCCEEEECCCC | 36.66 | - | |
260 | Sumoylation | KPIKGNTKISVANNQ CCCCCCCEEEECCCC | 36.66 | - | |
298 | Phosphorylation | QKCSGQLSQELPEAF CCCCCCHHHHCCHHH | 17.45 | 28348404 | |
342 | O-linked_Glycosylation | LSNKTPRSLSSQVDT HCCCCCCCHHHCCCC | 33.53 | 30379171 | |
342 | Phosphorylation | LSNKTPRSLSSQVDT HCCCCCCCHHHCCCC | 33.53 | 20363803 | |
344 | Phosphorylation | NKTPRSLSSQVDTPI CCCCCCHHHCCCCCC | 21.70 | 20363803 | |
345 | Phosphorylation | KTPRSLSSQVDTPIM CCCCCHHHCCCCCCC | 39.24 | 25159151 | |
349 | Phosphorylation | SLSSQVDTPIMTKSC CHHHCCCCCCCCCHH | 18.83 | 29396449 | |
354 | Ubiquitination | VDTPIMTKSCVTSCT CCCCCCCCHHHHCCC | 25.20 | 29967540 | |
359 | Phosphorylation | MTKSCVTSCTKEPET CCCHHHHCCCCCCCC | 10.21 | 21712546 | |
362 | Ubiquitination | SCVTSCTKEPETSNK HHHHCCCCCCCCCCC | 75.50 | - | |
414 | Sumoylation | TAHVTDQKEICTFNS CCCCCCCCCEEECCC | 52.43 | - | |
414 | Sumoylation | TAHVTDQKEICTFNS CCCCCCCCCEEECCC | 52.43 | 28112733 | |
414 | Ubiquitination | TAHVTDQKEICTFNS CCCCCCCCCEEECCC | 52.43 | 29967540 | |
418 | Phosphorylation | TDQKEICTFNSKTVK CCCCCEEECCCCCCC | 31.35 | 27174698 | |
421 | Phosphorylation | KEICTFNSKTVKNTS CCEEECCCCCCCCCC | 26.05 | 27174698 | |
422 | Acetylation | EICTFNSKTVKNTSR CEEECCCCCCCCCCC | 59.44 | 26051181 | |
423 | Phosphorylation | ICTFNSKTVKNTSRA EEECCCCCCCCCCCC | 36.21 | 27174698 | |
427 | Phosphorylation | NSKTVKNTSRANTSP CCCCCCCCCCCCCCC | 17.55 | 26074081 | |
428 | Phosphorylation | SKTVKNTSRANTSPD CCCCCCCCCCCCCCC | 38.50 | 27174698 | |
432 | Phosphorylation | KNTSRANTSPDARLG CCCCCCCCCCCCCCC | 40.42 | 26074081 | |
433 | Phosphorylation | NTSRANTSPDARLGD CCCCCCCCCCCCCCC | 22.16 | 28985074 | |
442 | Sumoylation | DARLGDSKVLQDLSS CCCCCCHHHHHHHHC | 52.26 | - | |
442 | Sumoylation | DARLGDSKVLQDLSS CCCCCCHHHHHHHHC | 52.26 | 28112733 | |
442 | Ubiquitination | DARLGDSKVLQDLSS CCCCCCHHHHHHHHC | 52.26 | 29967540 | |
450 | Ubiquitination | VLQDLSSKTYDRELI HHHHHHCCCCCHHHH | 47.96 | 29967540 | |
461 | Phosphorylation | RELIDAEYRFSPNSN HHHHCCEECCCCCCC | 20.76 | 28985074 | |
464 | Phosphorylation | IDAEYRFSPNSNKSN HCCEECCCCCCCCCC | 17.74 | 25159151 | |
469 | Ubiquitination | RFSPNSNKSNKLSTG CCCCCCCCCCCCCCC | 56.05 | 29967540 | |
470 | Phosphorylation | FSPNSNKSNKLSTGN CCCCCCCCCCCCCCC | 43.37 | 23532336 | |
480 | Sumoylation | LSTGNKMKFENSSNK CCCCCCEEEECCCCC | 51.65 | 28112733 | |
507 | Sumoylation | TSNLTKIKEDILTNS CCCCHHHHHHHHHCC | 51.38 | - | |
507 | Sumoylation | TSNLTKIKEDILTNS CCCCHHHHHHHHHCC | 51.38 | 28112733 | |
507 | Ubiquitination | TSNLTKIKEDILTNS CCCCHHHHHHHHHCC | 51.38 | 29967540 | |
514 | Phosphorylation | KEDILTNSTEASERK HHHHHHCCCHHHHHH | 23.53 | 25627689 | |
528 | Phosphorylation | KSALNTRYSNEQKNK HHHHHHCCCHHHHCC | 17.51 | - | |
529 | Phosphorylation | SALNTRYSNEQKNKC HHHHHCCCHHHHCCE | 30.51 | 25159151 | |
533 | Sumoylation | TRYSNEQKNKCILNQ HCCCHHHHCCEEECC | 52.80 | 28112733 | |
535 | Sumoylation | YSNEQKNKCILNQSI CCHHHHCCEEECCCC | 29.68 | - | |
535 | Sumoylation | YSNEQKNKCILNQSI CCHHHHCCEEECCCC | 29.68 | 28112733 | |
535 | Ubiquitination | YSNEQKNKCILNQSI CCHHHHCCEEECCCC | 29.68 | 29967540 | |
541 | Phosphorylation | NKCILNQSIKAPVNT CCEEECCCCCCCCCC | 25.61 | 25159151 | |
543 | Sumoylation | CILNQSIKAPVNTDL EEECCCCCCCCCCCC | 52.46 | - | |
543 | Sumoylation | CILNQSIKAPVNTDL EEECCCCCCCCCCCC | 52.46 | - | |
543 | Ubiquitination | CILNQSIKAPVNTDL EEECCCCCCCCCCCC | 52.46 | - | |
553 | Phosphorylation | VNTDLFGSANLGSKT CCCCCCCCCCCCCCC | 13.47 | 25159151 | |
559 | Ubiquitination | GSANLGSKTSVSNPN CCCCCCCCCCCCCCC | 42.92 | 29967540 | |
572 | Ubiquitination | PNQTSASKVGSFFDD CCCCCHHHHHHHCCC | 50.78 | 21963094 | |
575 | Phosphorylation | TSASKVGSFFDDWND CCHHHHHHHCCCCCC | 26.23 | 27732954 | |
584 | Phosphorylation | FDDWNDPSFANEIIK CCCCCCHHHHHHHHH | 39.59 | 27732954 | |
599 | Phosphorylation | ACHQLDNTWEADDVD HHHHCCCCCCCCCCC | 25.09 | 21712546 | |
611 | Phosphorylation | DVDDDLLYQACDDIE CCCHHHHHHHHHHHH | 11.02 | 27642862 | |
631 | Sumoylation | QDIRKDSKTSESICE HHHHHCCCCCHHHEE | 67.23 | - | |
631 | Sumoylation | QDIRKDSKTSESICE HHHHHCCCCCHHHEE | 67.23 | - | |
648 | Acetylation | NNSEHGAKLTQQQDI CCCHHHCCCHHHHHH | 57.57 | 26051181 | |
648 | Ubiquitination | NNSEHGAKLTQQQDI CCCHHHCCCHHHHHH | 57.57 | 29967540 | |
660 | Sumoylation | QDIRKDSKTSESICE HHHHHCCCCCHHEEH | 67.23 | - | |
660 | Sumoylation | QDIRKDSKTSESICE HHHHHCCCCCHHEEH | 67.23 | - | |
684 | Sumoylation | KNMFAISKQGSNLVQ CCEEEEECCCCCCEE | 53.19 | - | |
684 | Sumoylation | KNMFAISKQGSNLVQ CCEEEEECCCCCCEE | 53.19 | - | |
684 | Ubiquitination | KNMFAISKQGSNLVQ CCEEEEECCCCCCEE | 53.19 | 29967540 | |
717 | Sumoylation | SQIDKPMKMEKGEMY HHCCCCEEECCCCCC | 53.05 | - | |
717 | Sumoylation | SQIDKPMKMEKGEMY HHCCCCEEECCCCCC | 53.05 | - | |
720 | Ubiquitination | DKPMKMEKGEMYGNS CCCEEECCCCCCCCC | 57.59 | - | |
727 | Phosphorylation | KGEMYGNSPRFLGAT CCCCCCCCCCCCCCC | 17.06 | - | |
740 | Phosphorylation | ATNLTMYSKISNCQI CCCCEEEEECCCCEE | 16.82 | 24719451 | |
795 | Phosphorylation | TTYKKKLSTNQPCHK EEEHHHCCCCCCCCC | 33.90 | 25159151 | |
796 | Phosphorylation | TYKKKLSTNQPCHKT EEHHHCCCCCCCCCC | 48.59 | 25159151 | |
802 | Ubiquitination | STNQPCHKTVTDEAQ CCCCCCCCCCCHHHH | 51.94 | 29967540 | |
833 | Phosphorylation | MKNSQILSQFNQNCI ECHHHHHHHHHCCCC | 34.06 | 28112733 | |
856 | Ubiquitination | ITQGVEKKKGVNPLL CCCCCHHHCCCCHHH | 41.05 | 29967540 | |
857 | Ubiquitination | TQGVEKKKGVNPLLE CCCCHHHCCCCHHHH | 78.23 | 29967540 | |
874 | Ubiquitination | VGQQSLVKLSESLKQ HCCHHHHHHHHHHHH | 52.14 | 29967540 | |
880 | Ubiquitination | VKLSESLKQSSKEEE HHHHHHHHHHCHHHH | 58.37 | 29967540 | |
891 | Methylation | KEEEEKNRKCSPEEI HHHHHHHHCCCHHHH | 53.04 | - | |
894 | Phosphorylation | EEKNRKCSPEEIQRK HHHHHCCCHHHHHHH | 38.08 | 23663014 | |
916 | Phosphorylation | RMAKARASSVNAAPT HHHHHHHHHCCCCCC | 29.30 | 22617229 | |
917 | Phosphorylation | MAKARASSVNAAPTS HHHHHHHHCCCCCCC | 20.57 | 28555341 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ETAA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ETAA1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TZAP_HUMAN | ZBTB48 | physical | 26496610 | |
SP16H_HUMAN | SUPT16H | physical | 26496610 | |
SYTC2_HUMAN | TARSL2 | physical | 26496610 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-833, AND MASSSPECTROMETRY. |